These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12879634)

  • 21. Skeletal effects of statins.
    Yaturu S
    Endocr Pract; 2003; 9(4):315-20. PubMed ID: 14561578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
    Reid IR; Hague W; Emberson J; Baker J; Tonkin A; Hunt D; MacMahon S; Sharpe N
    Lancet; 2001 Feb; 357(9255):509-12. PubMed ID: 11229669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins in the management of aneurysmal subarachnoid hemorrhage: an overview of animal research, observational studies, randomized controlled trials and meta-analyses.
    Kramer AH
    Acta Neurochir Suppl; 2011; 110(Pt 2):193-201. PubMed ID: 21125471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins and stroke prevention.
    Paciaroni M; Bogousslavsky J
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1231-43. PubMed ID: 19814666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Coronary heart disease prevention. Are there differences in cholesterol synthesis inhibitors?].
    Müller-Wieland D; Faust M; Schleifenbaum T; Krone W
    MMW Fortschr Med; 2000 Jul; 142(30):26-8. PubMed ID: 10955015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of statins on bone mineral density.
    Yilmaz A; Arikan O; Dokmetas S
    Saudi Med J; 2006 Sep; 27(9):1433-5. PubMed ID: 16951794
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
    Hatzigeorgiou C; Jackson JL
    Osteoporos Int; 2005 Aug; 16(8):990-8. PubMed ID: 15744453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Statins: intervention studies, facts and perspectives].
    Durlach V
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 2):133-44. PubMed ID: 11240416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins and fracture risk.
    Meier CR; Schlienger RG; Kraenzlin ME; Schlegel B; Jick H
    JAMA; 2001 Aug; 286(6):669-70. PubMed ID: 11495608
    [No Abstract]   [Full Text] [Related]  

  • 30. Statins and fracture risk.
    Hennessy S; Strom BL
    JAMA; 2001 Apr; 285(14):1888-9. PubMed ID: 11308404
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cholesterol and statins in Alzheimer disease].
    Ransmayr G
    Wien Med Wochenschr; 2003; 153(11-12):258-9. PubMed ID: 12879635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review on the use of statins and tocotrienols, individually or in combination for the treatment of osteoporosis.
    Abdul-Majeed S; Mohamed N; Soelaiman IN
    Curr Drug Targets; 2013 Dec; 14(13):1579-90. PubMed ID: 23848479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Statins as a new therapeutic possibility in osteoporosis? Wishful thinking as opposed to data].
    Barthel HR
    Dtsch Med Wochenschr; 2001 Oct; 126(42):1189-90. PubMed ID: 11607863
    [No Abstract]   [Full Text] [Related]  

  • 34. [Statins and osteoporosis].
    Svejda P
    Vnitr Lek; 2006 Dec; 52(12):1190-3. PubMed ID: 17299913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Statins can maybe reduce the risk of venous thromboembolism].
    Toft-Petersen AP; Thomsen RW; Schmidt EB; Larsen TB
    Ugeskr Laeger; 2011 May; 173(22):1558-63. PubMed ID: 21627898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-lowering agents and the risk of hip fracture in a Medicaid population.
    Ray WA; Daugherty JR; Griffin MR
    Inj Prev; 2002 Dec; 8(4):276-9. PubMed ID: 12460961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins and bones.
    Moghadasian MH; Frohlich JJ
    CMAJ; 2001 Mar; 164(6):803-5. PubMed ID: 11276549
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of statins on coronary artery disease. Review of the recent publications].
    Bednarz B
    Przegl Lek; 2003; 60(1):27-9. PubMed ID: 12884643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.